4-Methylumbelliferone
Specifications
90-33-5CAS Number
201-986-7EC Number
7-hydroxy-4-methylchromen-2-oneIUPAC Name
C10H8O3Chemical Formula
176.17 g/molMolecular Weight
4-methylumbelliferone; Hymecromone; 90-33-5; 7-Hydroxy-4-methyl-2H-chromen-2-one; Imecromone; Cantabiline; Crodimon; Cholonerton; Hymecromon; Himecromona; Hymecromonum; Resocyanine; 2H-1-Benzopyran-2-one, 7-hydroxy-4-methyl-; 7-Hydroxy-4-methyl-2H-1-benzopyran-2-one; 7-Hydroxy-4-methyl-2-oxo-2H-1-benzopyran; 7-hydroxy-4-methylchromen-2-one; LM-94; 7-hydroxy-4-methyl-coumarin; 7-Hydroxy-4-methyl-2-oxo-3-chromene; DTXSID8025670; NSC-9408; NSC-19026; 4 Methylumbelliferone; 3T5NG4Q468; DTXCID805670; CHEBI:17224; Coumarin 456; Imechromone; Eurogae; RefChem:389056; 7 Hydroxy 4 methyl coumarin; A05AX02; 201-986-7; 7-HYDROXY-4-METHYLCOUMARIN; beta-Methylumbelliferone; 4-Methyl-7-hydroxycoumarin; Cholestil; Mendiaxon; Coumarin 4; 4-MU; Bilcolic; Bilicante; Cantabilin; Eurogale; Medilla; 4-Methylumbelliferon; Cumarote-C; Omega 127; Pilot 447; 79566-13-5; 7-hydroxy-4-methyl-chromen-2-one; 2-Hydroxy-4-methyl-7H-chromen-7-one; LM 94; NSC 9408; MFCD00006866; NSC 19026; Coumarin, 7-hydroxy-4-methyl-; 2-Hydroxy-4-methyl-7H-1-benzopyran-7-one; 2H-1-Benzopyran, 7-hydroxy-4-methyl-2-oxo-; 2H-1-Benzopyren-2-one, 7-hydroxy-4-methyl-; 4-Methylumbelliferone (4-MU); NSC9408; NSC19026; .beta.-Methylumbelliferone; 7-hydroxy-4-methyl coumarin; 4-Methyl-7-hydroxy-coumarin; CHEMBL12208; 7H-1-Benzopyran-7-one, 2-hydroxy-4-methyl-; CAS-90-33-5; NCGC00016345-01; Imecromone [DCIT]; METHYLUMBELLIFERONE, BETA; WLN: T66 BOVJ E1 IQ; Cholspasmin; Hymechrome; Himecol; Hymecromonum [INN-Latin]; Himecromona [INN-Spanish]; SMR000471886; 4-Methylumbelliferon [Czech]; CCRIS 5926; EINECS 201-986-7; BRN 0142217; Hymechromone; UNII-3T5NG4Q468; Cantabiline;; Hymecromone;; AI3-08085; Hymecromone CRS; Biliton H; Cantabiline (TN); Coumarin 4;; 4MU; Hymecromone [USAN:INN:BAN:JAN]; ZZ1; ss-Methylumbelliferone; 4-methyl umbelliferone; 4-Methyl-umbelliferone; 4-Methylumbelliferone;; Coumarin derivative, 3b; Pilot 447;; HYMECROMONE [MI]; Maybridge1_002078; Prestwick0_000901; Prestwick1_000901; Prestwick2_000901; Prestwick3_000901; HYMECROMONE [INN]; HYMECROMONE [JAN]; Umbelliferone, 4-methyl-; HYMECROMONE [USAN]; Methylumbelliferone, .beta.; 4-methyl-7-hydroxy-cumarin; HYMECROMONE [MART.]; 4-methyl-7-hydroxy coumarin; SCHEMBL24150; BSPBio_000742; HYMECROMONE [WHO-DD]; 5-18-01-00439 (Beilstein Handbook Reference); 7-hydroxy-4-methyl coumarine; MLS001074671; MLS004491718; SCHEMBL169915; 4-Methyl-7-hydroxyl Coumarin; SPBio_002941; BPBio1_000818; MEGxp0_001898; orb1223700; orb1308758; SCHEMBL4831773; SCHEMBL6385935; 7-hydroxy-4-methyl-2-coumarin; 4-Methylumbelliferone, >=98%; SCHEMBL27955965; SCHEMBL29364837; SCHEMBL30424058; ACon1_002401; cid_5280567; HMS547G10; HY-N0187R; Hymecromone (JP18/USAN/INN); 4-Methylumbelliferone (Standard); GLXC-10598; HMS1570F04; HMS2097F04; HMS2267L19; HMS3264E04; HMS3655L16; HMS3714F04; HMS5080K20; HYMECROMONE [EP MONOGRAPH]; Pharmakon1600-01506174; ALBB-036660; HY-N0187; MSK10766; Tox21_110385; Tox21_300915; BBL000531; BDBM50022178; CCG-47894; EBC-13723; NSC760397; s2256; SBB009085; STK364326; 7-Hydroxy-4-methyl-2H-2-chromenone; AKOS000119370; Tox21_110385_1; CS-7560; DB07118; EM16008; FM00596; NSC-760397; 7-Hydroxy-4-methylcoumarin, Hymecromone; NCGC00016345-02; NCGC00016345-03; NCGC00016345-04; NCGC00016345-05; NCGC00016345-08; NCGC00016345-09; NCGC00016345-12; NCGC00169880-01; NCGC00169880-02; NCGC00257522-01; 2H-Chromen-2-one, 7-hydroxy-4-methyl-; 7-Hydroxy-4-methyl-2H-chromen-2-one #; AC-22306; AS-13247; NCI60_042099; SY017941; DB-029370; AB00443536; M0453; NS00010646; ST50102505; SW197287-3; EN300-16753; C03081; D00170; D70647; M-5410; M-5421; 7-Hydroxy-4-methylcoumarin|4-Methylumbelliferone; AB00443536_08; AE-848/01238044; F093391; Q904431; SR-01000637483; SR-01000637483-1; SR-01000637483-3; BRD-K46424862-001-02-6; BRD-K46424862-001-04-2; BRD-K46424862-001-14-1; BRD-K46424862-001-15-8; Z56763041; F0849-0318; F1918-0038Synonyms